Skip to main content
. 2023 Sep 27;15(19):4750. doi: 10.3390/cancers15194750

Figure 2.

Figure 2

Figure 2

Figure 2

Survival rates in stages I–II vs. III at 5 years. (a) Cancer-specific survival. (b) Disease-free survival. (c) Local-relapse (uterus)-free survival. (d) Lymph node relapse-free survival (LRRFS). (e) Distant metastasis-free survival.